Mic Capital Management Uk LLP Recursion Pharmaceuticals, Inc. Transaction History
Mic Capital Management Uk LLP
- $416 Million
- Q2 2024
A detailed history of Mic Capital Management Uk LLP transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Mic Capital Management Uk LLP holds 8,451,758 shares of RXRX stock, worth $50 Million. This represents 15.23% of its overall portfolio holdings.
Number of Shares
8,451,758
Previous 8,451,758
-0.0%
Holding current value
$50 Million
Previous $84.3 Million
24.77%
% of portfolio
15.23%
Previous 18.12%
Shares
2 transactions
Others Institutions Holding RXRX
# of Institutions
285Shares Held
236MCall Options Held
972KPut Options Held
2.4M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl28.1MShares$167 Million1.92% of portfolio
-
Baillie Gifford & CO26.6MShares$157 Million0.16% of portfolio
-
Vanguard Group Inc Valley Forge, PA21.6MShares$128 Million0.0% of portfolio
-
Black Rock Inc. New York, NY17.3MShares$102 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA15.4MShares$91.1 Million1.74% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $1.07B
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...